Try our Advanced Search for more refined results
Human Genome Sciences, Inc.
-
Misc | Filed: April 13, 2022 | Entered: April 13, 2022 DRIT LP v. Glaxo Group Limited et al
Patent | Delaware
Letter
Letter to Prothonotary from Clerk USDC/DE regarding Remand Order. (ntl)
-
Utility | Filed: April 13, 2022 | Entered: April 13, 2022 DRIT LP v. Glaxo Group Limited et al
Patent | Delaware
Terminate Case - Civil
CASE CLOSED (ntl)
-
Order | Filed: March 29, 2022 | Entered: March 29, 2022 DRIT LP v. Glaxo Group Limited et al
Patent | Delaware
Order - -Memorandum and Order
MEMORANDUM ORDER: IT IS HEREBY ORDERED that GSK's objections (D.I. 22) are OVERRULED, the Report (D.I. 21) is ADOPTED, and the pending portion of DRIT's motion to remand (D.I. 4) is GRANTED. IT IS FURTHER ORDERED that the pending motion to dismiss (D.I. 12) is DENIED AS MOOT. The Clerk of Court is directed to CLOSE this case. Signed by Judge Leonard P. Stark on 3/29/22. (ntl)
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Archive of over 450,000 articles
- Database of over 2.1 million cases
- 62,000+ organization-specific pages.
- Daily and real-time news and case alerts on organizations, industries, and customized search queries.
- Significant legal events involving law firms, companies, industries, and government agencies.
- Learn more
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login